AuntMinnie

NOVEMBER 1, 2024

After many years of advocacy by the American College of Radiology, the Centers for Medicare and Medicaid Services (CMS) will cover CT colonography (CTC) for colorectal cancer (CRC) screening beginning January 1," the college wrote. The ACR lauded the CMS for the colorectal cancer screening coverage.

Radiopharmaceuticals 213

Radiopharmaceuticals Medicare Computed Tomography Hospital 213

AuntMinnie

APRIL 15, 2024

decrease in hospital-based studies and a 2.5% decrease in total procedures each year, with hospital-based procedures declining by 5.5% and non-hospital procedures increasing by 1.2%. million were performed in hospital sites and 4.1 Total nuclear medicine patient study volumes decreased by 5.7% Of these, 5.8

Nuclear Medicine 279

Nuclear Medicine Hospital Radiopharmaceuticals Radiologist 279

Imaging Technology

MAY 14, 2024

milla1cf Tue, 05/14/2024 - 12:45 May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. New research will partially involve the company’s 0.55T mid-field scanner that requires less than one liter of helium.

Hospital 116

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 116

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 306

AuntMinnie

NOVEMBER 4, 2024

Radiological societies have mixed views on the U.S. Centers for Medicare & Medicaid Services (CMS) 2025 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules. Although the 2025 MPFS calls for an overall 2.9% Although the 2025 MPFS calls for an overall 2.9%

Radiation Oncology 200

Radiation Oncology Nuclear Medicine Medicare Imaging 200

Imaging Technology

FEBRUARY 21, 2024

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 104

Clinic Radiopharmaceuticals Nuclear Medicine Hospital 104

Imaging Technology

JANUARY 27, 2025

The Care Innovation Hub leverages the strengths of academia and industry to create, evaluate and translate novel technology into a clinical setting with the goals of advancing diagnosis and treatment of disease, improving hospital operations and driving more equitable access to care. tim.hodson Mon, 01/27/2025 - 10:11 Jan.

Healthcare 59

Healthcare Healthcare Magnetic Resonance Imaging Disease 59

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. Hope, vice chair of clinical operations and strategy in the UCSF department of radiology, established the radioligand therapy group at the university. However, few freestanding theranostics centers exist today. Hope added.

Nuclear Medicine 222

Nuclear Medicine Radiation Oncology Nursing Radiation 222

AuntMinnie

FEBRUARY 20, 2024

Blue Earth Therapeutics is highlighting early clinical results from a German trial investigating the use of a lutetium-177 (Lu-177)-labeled prostate specific antigen (PSMA) radiopharmaceutical. and its findings were published in December in the Journal of Nuclear Medicine.

Clinic 100

Clinic Nuclear Medicine Radiopharmaceuticals Hospital 100

AuntMinnie

JUNE 9, 2024

Urbain, a professor of radiology and nuclear medicine, has served in multiple roles within SNMMI, in addition to his most recent post as vice president-elect. He currently serves as a staff physician at Stratford General Hospitals in Ontario, in addition to his consulting and academic center activities. Jean-Luc Urbain, MD, PhD. “As

Nuclear Medicine 100

Nuclear Medicine Radiopharmaceuticals Government Education 100

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 130

Imaging Technology

JUNE 26, 2023

He performed doctoral and post-doctoral work at Memorial Sloan Kettering Cancer Center and completed his radiology residency at Massachusetts General Hospital. Mahmood has held many volunteer leadership positions throughout the course of his career.

Nuclear Medicine 98

Nuclear Medicine Education Radiopharmaceuticals Hospital 98

Imaging Technology

JUNE 11, 2024

She will also raise awareness of nuclear medicine’s value to clinical colleagues and patients and will be laser-focused on breaking down barriers to radiopharmaceutical availability, reimbursement, affordability, and funding. An active SNMMI member, Jacene has been involved in many aspects of the organization.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Patient Care Medical 52

Imaging Technology

JUNE 10, 2024

Urbain, MD, PhD, FASNC, professor of Radiology/Nuclear Medicine and Medicine, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). As SNMMI president-elect, I plan to focus on bringing and integrating radiopharmaceutical theranostics into the clinic to benefit as many patients as possible.

Nuclear Medicine 45

Nuclear Medicine Radiopharmaceuticals Health Science Hospital 45

Imaging Technology

JUNE 20, 2024

When produced in combination with the company’s TRACERcenter – which is designed to serve as a complete PET radiopharmacy solution – the resulting radiopharmaceuticals can help physicians identify and diagnose clinical signs across care areas – including oncology, cardiology, and neurology.

Healthcare 104

Healthcare Healthcare Nuclear Medicine Computed Tomography 104

Imaging Technology

APRIL 2, 2024

These new capabilities align with our precision care strategy to personalize care, enhance hospital efficiency and clinician effectiveness, and appeal to new and existing GE HealthCare and MIM Software users who see this as an opportunity to better serve patients and help improve outcomes."

Healthcare 105

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 105

Future Teleradiology

NOVEMBER 21, 2023

Teleradiology & Radiology data for artificial intelligence (AI) Introduction: Nuclear medicine, a dynamic and rapidly evolving field, continues to break new ground in diagnostic and therapeutic approaches. Advancements in Radiopharmaceuticals: Precision Imaging Agents: Discuss the latest developments in radiopharmaceuticals.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Teleradiology 52

AuntMinnie

OCTOBER 2, 2024

This year, hundreds of candidates have been selected as semifinalists for 14 categories, ranging from Most Influential Radiology Researcher to Best New Radiology Software. The semifinalist list was compiled based on nominations from members of AuntMinnie.com. Winners will be selected by our expert panel in two rounds of voting.

Digital Imaging and Communications in Medicine 360

Digital Imaging and Communications in Medicine X-ray MRI Hospital 360

Global Radiology CME

DECEMBER 21, 2024

A nuclear medicine hepatobiliary scan was also performed (not shown) and demonstrated no radiopharmaceutical present in the gallbladder due to cystic duct obstruction. He serves as chair for his schools radiology interest group. Rice, MD is the president of Global Radiology CME and is a radiologist with Cape Radiology Group.

Education 52

Education Global Radiology Nuclear Medicine Ultrasound 52